News
Stay up to date on the latest crypto trends with our expert, in-depth coverage.
1Bitget UEX Daily | Fed Dot Plot Turns Sharply Hawkish; Micron Blowout Guidance Reverses to Sharp Drop; Middle East Oil & Gas Facilities Attacked (March 19, 2026)2Micron Technology (MU) Fiscal 2026 Q2 Earnings: Revenue Nearly Triples in Explosive Growth, EPS Significantly Beats Expectations, Q3 Guidance Midpoint Soars to Record-High $33.5 Billion!3Bitcoin falls under $71K but data shows BTC’s bullish momentum holding
Silent Revolution: The Cryptocurrency Market is Undergoing a "Wealth Redistribution"
AICoin·2025/11/14 09:12
Ethereum Crash Revelation: Leverage Liquidations and Volatility Amid Macroeconomic Shadows
AICoin·2025/11/14 09:11
Undercurrents in the Race for Federal Reserve Chair: "Draining Wall Street" Becomes the Core Issue
Trump desires low interest rates, but the Federal Reserve chair candidates he favors advocate for restricting the central bank's primary tool for achieving low rates—quantitative easing.
ForesightNews·2025/11/14 09:02
Options exchange Cboe enters the prediction market, focusing on financial and economic events
Options market pioneer Cboe has announced its entry into the prediction market. Instead of following the sports trend, it is firmly taking a financially sound path and plans to launch its own products linked to financial outcomes and economic events.
ForesightNews·2025/11/14 09:01
Uniswap Labs' "fee switch" activated: a mysterious move or the next narrative wave?
Bitpush·2025/11/14 09:00
How the Grayscale IPO changes the cost to hold $35 billion crypto ETF shares
CryptoSlate·2025/11/14 09:00
Grayscale’s IPO filing reveals strategic shift amid revenue dip
CryptoSlate·2025/11/14 09:00
Grayscale submits IPO application: The crypto giant with $35 billion in assets under management finally approaches the US stock market
The $35 billion includes ETPs and ETFs with $33.9 billion in assets under management (mainly Bitcoin, Ethereum, and SOL related products), as well as $1.1 billion in private funds.
BlockBeats·2025/11/14 08:31
The $100,000 threshold is hard to hold, bitcoin leads the decline, and the risk-aversion storm fully escalates.
A wave of risk is sweeping across global assets, with US stocks plunging simultaneously.
ForesightNews 速递·2025/11/14 08:03
Flash
14:27
Algorand Foundation completes strategic integration, will take over protocol development and IP, and commits to investing $15 millionForesight News reported that the Algorand Foundation and Algorand Technologies have announced an agreement under which the intellectual property of Algorand Technologies and the development and support activities of the Algorand protocol will be integrated into the Algorand Foundation. According to the agreement, the Algorand Foundation will commit at least $15 million for the technical maintenance, enhancement, and support of the Algorand protocol.The Algorand Foundation stated that this integration marks the completion of its transition to a unified US headquarters structure, with social media accounts and marketing assets also being transferred to the Foundation. Previously, the Foundation had relocated its global headquarters to Delaware and completed the appointment of a new board of directors.
14:12
US Stock Market Movement | Brent Oil Surged to $119 per Barrel Intraday, Some Oil and Gas Resource Stocks Rose格隆汇 March 19｜Some oil and gas resource stocks rose, Woodside Energy surged over 9%, Apache Oil rose over 6%, Total and BP climbed over 3%, Devon Energy and Occidental Petroleum rose over 2%. In terms of news, as Israel launched an attack on Iran's South Pars gas field on Wednesday local time, the Islamic Revolutionary Guard Corps of Iran announced that multiple energy facilities in three Middle Eastern countries have been designated as "legitimate targets." In addition, Kuwait Oil Company stated on Thursday that a production unit at the MINA AL-AHMADI refinery was attacked by a drone, causing a small-scale fire. Brent crude oil briefly spiked to $119 per barrel during the day.
14:10
Gilead Sciences (GILD.US) initiates Phase III clinical trial for CD19/CD20 CAR-T cell therapyKITE-753 is an autologous CAR-T cell therapy targeting CD19 and CD20 with dual cis-regulatory elements.
News